← Back
Data updated: Mar 10, 2026
ATHENA
Cardiovascular
ATHENA is a pharmaceutical company focused on Cardiovascular. Key products include QDOLO.
2009
Since
3
Drugs
-
Trials
3
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 100%
1 drugs
Pipeline Strength Pro
Loading...
Active (1)
Company Info
- First Approval
- 2009-08-14
- Latest
- 2025-12-22
- Applications
- 3